Ensign Peak Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $678M | Sell |
|
|||||
|
2025
Q1 | $740M | Buy |
|
|||||
|
2024
Q4 | $679M | Buy |
|
|||||
|
2024
Q3 | $776M | Sell |
|
|||||
|
2024
Q2 | $808M | Sell |
|
|||||
|
2024
Q1 | $721M | Buy |
|
|||||
|
2023
Q4 | $411M | Buy |
|
|||||
|
2023
Q3 | $316M | Sell |
|
|||||
|
2023
Q2 | $411M | Buy |
|
|||||
|
2023
Q1 | $243M | Buy |
|
|||||
|
2022
Q4 | $153M | Buy |
|
|||||
|
2022
Q3 | $125M | Buy |
|
|||||
|
2022
Q2 | $90.3M | Sell |
|
|||||
|
2022
Q1 | $143M | Sell |
|
|||||
|
2021
Q4 | $178M | Sell |
|
|||||
|
2021
Q3 | $157M | Sell |
|
|||||
|
2021
Q2 | $231M | Sell |
|
|||||
|
2021
Q1 | $196M | Buy |
|
|||||
|
2020
Q4 | $130M | Sell |
|
|||||
|
2020
Q3 | $125M | Buy |
|
|||||
|
2020
Q2 | $134M | Buy |
|
|||||
|
2020
Q1 | $36.8M | Sell |
|
|||||
|
2019
Q4 | $39M | Buy |
|